NCT05321550

Brief Summary

This experimental study will investigate whether the decreased NFR threshold and increased NFR temporal summation, which are frequently observed in chronic pain patients, are only symptomatic manifestations that occur in the involved limb and indicate peripheral sensitization or generalized manifestations that are also present in the non-involved limbs and thus indicate central sensitization. To gain an idea of the presence of central sensitization, this study will also investigate whether there are increased perception and decreased pain thresholds in response to electrical, thermal, and mechanical stimulation, as well as whether there is a decreased conditioned pain modulation. To investigate this, it is essential to examine different pain populations and locations, in particular, acute pain versus chronic pain populations to compare peripheral versus central sensitization, respectively. Recently, our research group has shown that patients with a traumatic origin of chronic neck pain (chronic whiplash-associated disorders) show central sensitization in contrast to patients with a non-traumatic origin (chronic idiopathic neck pain) who demonstrate only indications for peripheral sensitization. Therefore, this study will also distinguish between complaints of traumatic and non-traumatic origin. The measurements will be performed at different locations, namely the lower and upper limbs. To determine whether the differences depend on the measurement location (= location where experimental nociceptive stimulation is administered) and symptom location (= location of clinical nociceptive stimulation), different patient populations will be compared with each other, as well as with a healthy control population. In acute and chronic whiplash patients and patients with acute and chronic idiopathic neck pain complaints, the complaints are primarily localized in the upper limb. It is hypothesized that in chronic neck pain patients (both whiplash and idiopathic neck pain patients) abnormal values are found in both the upper and lower limbs compared to the healthy controls due to central sensitization. In acute neck pain patients (both whiplash and idiopathic neck pain) only abnormal values in the arm are expected and not in the leg as a result of peripheral sensitization. It is hypothesized that patients with neck pain of traumatic origin will show a stronger sensitization than those with neck pain of non-traumatic origin. In acute and chronic low back pain patients, the complaints are primarily localized in the lower body quadrant. As a result of central sensitization in the chronic low back pain patients, abnormal values are expected in both the upper and lower limbs, while only abnormal values in the leg are expected as a result of peripheral sensitization in the acute low back pain patients. Finally, this study will investigate whether chronic low back and neck pain patients show a similar pattern of central sensitization as fibromyalgia patients, a population with generalized complaints that are primarily attributed to central sensitization.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
240

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 22, 2022

Completed
20 days until next milestone

First Posted

Study publicly available on registry

April 11, 2022

Completed
10 days until next milestone

Study Start

First participant enrolled

April 21, 2022

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2024

Completed
Last Updated

January 5, 2024

Status Verified

January 1, 2024

Enrollment Period

2.4 years

First QC Date

March 22, 2022

Last Update Submit

January 4, 2024

Conditions

Outcome Measures

Primary Outcomes (12)

  • Quantitative sensory testing (QST) - electrical detection threshold

    Determination of sensory detection thresholds in response to electrical stimuli which are delivered transcutaneously over the n. suralis and n. medianus, recorded in mA.

    Baseline

  • Quantitative sensory testing (QST) - electrical pain threshold

    Determination of sensory pain threshold in response to electrical stimuli which are delivered transcutaneously over the n. suralis and n. medianus, recorded in mA.

    Baseline

  • Quantitative sensory testing (QST) - thermal detection threshold

    Determination of sensory detection thresholds in response to thermal stimuli which are delivered to the skin using a thermode, recorded in °C: * cold detection threshold * warmth detection threshold

    Baseline

  • Quantitative sensory testing (QST) - thermal pain threshold

    Determination of sensory pain thresholds in response to thermal stimuli which are delivered to the skin using a thermode, recorded in °C: * cold pain threshold * heat pain threshold

    Baseline

  • Quantitative sensory testing (QST) - discrimination between thermal stimuli

    Determination of the number of paradoxical heat sensations in response to alternating cold and warm stimuli delivered to the skin using a thermode.

    Baseline

  • Quantitative sensory testing (QST) - tactile detection threshold

    Determination of tactile detection threshold, assessed using Von Frey monofilaments, recorded in mN

    Baseline

  • Quantitative sensory testing (QST) - mechanical pain threshold

    Determination of mechanical pain threshold, assessed using pinprick stimulators, recorded in mN

    Baseline

  • Quantitative sensory testing (QST) - sensitivity to pressure stimuli

    Determination of pressure pain threshold, assessed using pressure algometry, recorded in kg

    Baseline

  • Quantitative sensory testing (QST) - temporal summation of electrical stimuli

    Determination of temporal summation in response to electrical stimuli delivered transcutaneously over the skin of the n. suralis and n. medianus. The numerical pain rating in response to these stimuli (range 0 - 100) will be recorded.

    Baseline

  • Quantitative sensory testing (QST) - spinal hyperexcitability

    Determination of spinal hyperexcitability using the nociceptive flexion reflex (NFR; sensitization of spinal cord neurons), recorded in mA

    Baseline

  • Quantitative sensory testing (QST) - temporal summation of spinal hyperexcitability

    Determination of temporal summation of the nociceptive flexion reflex (NFR; sensitization of spinal cord neurons), recorded using a numeric pain rating scale (range 0 - 100)

    Baseline

  • Quantitative sensory testing - conditioned pain modulation

    Determination of condition pain modulation (aka. pain inhibits pain) by means of a heterotopic noxious counterstimulation paradigm. Test stimuli comprise of pressure pain threshold assessments and application of a heat stimulus (using a thermode) corresponding to a temperature eliciting a visual analog scale rating of 5/10. Test stimuli will be applied before, during and after the conditioning stimulus which is the immersion of the hand in a hot circulating water bath of 45.5°C.

    Baseline

Secondary Outcomes (14)

  • Central sensitization inventory

    Baseline

  • Douleur Neuropathique 4 Questionnaire

    Baseline

  • Pain catastrophizing scale

    Baseline

  • Pain vigilance and awareness questionnaire

    Baseline

  • Tampa scale for kinesiophobia

    Baseline

  • +9 more secondary outcomes

Study Arms (4)

Fibromyalgia patients

Fibromyalgia patients diagnosed according to the 2010 ACR-criteria

Neck pain patients

* Patients with non-specific, idiopathic neck pain complaints * Patients with neck pain complaints of traumatic origin type whiplash grade 1 (pain, stiffness or tenderness of the neck and no objective physical abnormalities) and grade 2 (neck complaints and musculoskeletal disorders such as reduced range of motion and tender pain points) according to the Quebec Task Force on Whiplash Associated Disorders

Low back pain patients

Patients with non-specific, idiopathic back pain complaints

Healthy controls

Age, sex and BMI-matched healthy controls

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

* Fibromyalgia patients (n=30) diagnosed according to the 2010 ACR-criteria * Patients with non-specific, idiopathic neck pain complaints which are acute (n=30) or chronic (n=30) * Patients with neck pain complaints of traumatic origin type whiplash grade 1 (pain, stiffness or tenderness of the neck and no objective physical abnormalities) and grade 2 (neck complaints and musculoskeletal disorders such as reduced range of motion and tender pain points) according to the Quebec Task Force on Whiplash Associated Disorders which is acute (n=30) or chronic (n=30) * Patients with non-specific, idiopathic back pain complaints which are acute (n=30) or chronic (n=30) * Healthy controls (n=30) matched based on age, sex and BMI

You may qualify if:

  • \- diagnosed according to 2010 ACR-criteria
  • \- having idiopathic neck pain complaints or having grade 1 (pain, stiffness or tenderness of the neck and without objective physical abnormalities) or grade 2 (neck complaints and musculoskeletal disorders such as decreased range of motion and tender pain points) according to the Quebec Task Force on Whiplash Associated Disorders
  • \- having idiopathic low back pain complaints
  • no history of serious pain complaints (e.g. severe migraine, fibromyalgia, etc.)
  • no low back or neck pain complaints with an intensity of ≥2/10 on a visual analogue scale in the past year and of such severity that the daily activities were disrupted and a (para)medic was consulted

You may not qualify if:

  • history of severe respiratory (e.g. cystic fibrosis), orthopedic (e.g. whiplash trauma), neurological (e.g. cerebrovascular incident), cardiovascular (e.g. severe hypertension), or endocrinological (e.g. diabetes) disorders
  • recent psychological trauma (e.g. post-traumatic stress disorder)
  • history of spinal surgery (e.g. lumbar discectomy), spinal trauma (e.g. vertebral fracture), or severe spinal deformities (e.g. spondylolisthesis)
  • BMI ≥35 (due to potential difficulties in obtaining an NFR in severely overweight individuals)
  • pregnancy, lactation, or within 1 year postpartum

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ghent University

Ghent, Belgium

RECRUITING

MeSH Terms

Conditions

FibromyalgiaNeck PainLow Back PainWhiplash Injuries

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBack PainNeck InjuriesWounds and Injuries

Study Officials

  • Jessica Van Oosterwijck

    University Ghent

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jessica Van Oosterwijck

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 22, 2022

First Posted

April 11, 2022

Study Start

April 21, 2022

Primary Completion

October 1, 2024

Study Completion

October 1, 2024

Last Updated

January 5, 2024

Record last verified: 2024-01

Locations